Singapore, Oct. 31 -- Australia-based CSL Seqirus and Vaccine Industrial Company have signed a Memorandum of Understanding with the Ministry of Health of Saudi Arabia to enhance the biotechnology sector by accessing advanced cell-based seasonal and pandemic influenza vaccines and localizing manufacturing in Saudi Arabia.

Under a finalised agreement, CSL Seqirus, a leading global influenza vaccine manufacturer, would provide its innovative cell-based seasonal and pandemic influenza vaccines and work with Vaccine Industrial Company (VIC), a prominent Saudi vaccine company, to localize manufacturing at VIC's new Sudair City facility.

The finalised agreement would also establish pre-pandemic vaccine stockpiles for high-risk populations and ...